Kathleen C. Barracchini

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.

Janice N. Cormier, Michael L. Salgaller, Tracy Prevette et al. · PubMed · 1997 · 277 citations

Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.

Licia Rivoltini, Kathleen C. Barracchini, Vincenzo Viggiano et al. · PubMed · 1995 · 164 citations

Histocompatibility, Hla, Mhc Class +21

Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy

Licia Rivoltini, Douglas J. Loftus, Kathleen C. Barracchini et al. · The Journal of Immunology · 1996 · 78 citations

Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification

Sharon Adams, Kathleen C. Barracchini, Deborah Chen et al. · Journal of Translational Medicine · 2004 · 72 citations · Full text

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.

Roya Dadmarz, A Ordoubadi, Arnold Mixon et al. · PubMed · 2006 · 55 citations